Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients

NCT07308457 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Incidence of Infectious Diseases

Interventions

DRUG: Ceftriaxone 1000 MG

Sponsor

Pomeranian Medical University Szczecin